(Q34301521)

1 August 2017

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study (English)

1 reference

1 August 2017

0 references

0 references

9

1 reference

1 August 2017

Patrice Dubreuil

7

0 references

author name string

Patrick Vermersch

1

1 reference

1 August 2017

Rabah Benrabah

2

1 reference

1 August 2017

Nicolas Schmidt

3

1 reference

1 August 2017

Hélène Zéphir

4

1 reference

1 August 2017

Pierre Clavelou

5

1 reference

1 August 2017

Cyrille Vongsouthi

6

1 reference

1 August 2017

Alain Moussy

8

1 reference

1 August 2017

12 June 2012

1 reference

1 August 2017

1 reference

1 August 2017

12

1 reference

1 August 2017

36

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-12-36

1 August 2017

0 references

cites work

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Progressive multiple sclerosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Brain mast cells link the immune system to anxiety-like behavior

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

The essential role of mast cells in orchestrating inflammation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Nitric oxide and multiple sclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Critical role of mast cells in inflammatory diseases and the effect of acute stress

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Mechanisms underlying mast cell influence on EAE disease course

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Mast cells as a source and target for nitric oxide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Mast cells migrate from blood to brain.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Defining the clinical course of multiple sclerosis: Results of an international survey

6 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

6 July 2018

https://api.crossref.org/works/10.1186%2F1471-2377-12-36

Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467179

Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-12-36

Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-12-36

Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-12-36

Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-12-36

Primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-12-36

Human mast cells stimulate activated T cells: implications for multiple sclerosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22691628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Relapses and progression of disability in multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22691628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22691628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-12-36

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference